- Home
- ALT vs LE Comparison
ALT vs LE Comparison
Compare ALT & LE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALT
- LE
- Stock Information
- Founded
- ALT 1997
- LE 1963
- Country
- ALT United States
- LE United States
- Employees
- ALT 59
- LE N/A
- Industry
- ALT Biotechnology: Pharmaceutical Preparations
- LE Clothing/Shoe/Accessory Stores
- Sector
- ALT Health Care
- LE Consumer Discretionary
- Exchange
- ALT Nasdaq
- LE Nasdaq
- Market Cap
- ALT 501.9M
- LE 440.4M
- IPO Year
- ALT N/A
- LE N/A
- Fundamental
- Price
- ALT $4.86
- LE $14.59
- Analyst Decision
- ALT Strong Buy
- LE Strong Buy
- Analyst Count
- ALT 7
- LE 2
- Target Price
- ALT $16.33
- LE $20.00
- AVG Volume (30 Days)
- ALT 3.2M
- LE 153.6K
- Earning Date
- ALT 11-06-2025
- LE 12-04-2025
- Dividend Yield
- ALT N/A
- LE N/A
- EPS Growth
- ALT N/A
- LE N/A
- EPS
- ALT N/A
- LE 0.19
- Revenue
- ALT $20,000.00
- LE $1,315,578,000.00
- Revenue This Year
- ALT N/A
- LE $2.21
- Revenue Next Year
- ALT N/A
- LE $2.44
- P/E Ratio
- ALT N/A
- LE $72.22
- Revenue Growth
- ALT N/A
- LE N/A
- 52 Week Low
- ALT $2.90
- LE $7.65
- 52 Week High
- ALT $10.88
- LE $16.87
- Technical
- Relative Strength Index (RSI)
- ALT 68.61
- LE 42.52
- Support Level
- ALT $4.40
- LE $13.63
- Resistance Level
- ALT $4.75
- LE $15.56
- Average True Range (ATR)
- ALT 0.29
- LE 0.81
- MACD
- ALT 0.07
- LE -0.26
- Stochastic Oscillator
- ALT 95.22
- LE 29.41
About ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About LE Lands' End Inc.
Lands' End Inc is a United States-based multi-channel retailer of casual clothing, accessories, and footwear, as well as home products. The company's operating segment includes U.S. eCommerce; International; Outfitters; Third Party and Retail. It generates maximum revenue from the U.S. eCommerce segment. The U.S. eCommerce segment offers products through the company's eCommerce website. Geographically operates in USA, Europe, Asia, it derives a majority of its revenue from the United States.